Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening sideeffect
that can occur in response to treatment with antipsychotic drugs. Symptoms commonly …

One of the most widely used guides to prescribing psychiatric medications, the Tenth Edition
of Maudsley Prescribing Guidelines returns with fully updated content and new sections on …

Purpose Neuroleptic malignant syndrome (NMS) is a rare and life threatening condition
usually defined as a complication of treatment with antipsychotics characterized by severe …

Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal adverse event
associated with the use of antipsychotics. Although atypical antipsychotics were initially …

Results A total of 20 cases had met the criteria for atypical NMS [[21],[22],[23],[24],[25],[26],[
27],[28],[29],[30],[31],[32],[33],[34],[35],[36],[37],[38],[39],[40],[41]]. Profile of cases and details …

Objective: Neuroleptic malignant syndrome induced by atypical antipsychotics presents
atypical clinical manifestations with fewer symptoms compared with neuroleptic malignant …

Neuroleptic malignant syndrome (NMS) is a rare, but severe adverse drug reaction of drugs
with anti-dopaminergic properties. The main symptoms are fever and rigor. In addition, other …

INTRODUCTION—Neuroleptic malignant syndrome (NMS) is a life-threatening neurologic
emergency associated with the use of antipsychotic (neuroleptic) agents and characterized …

Atypical antipsychotics and selective serotonin reuptake inhibitors (SSRIs) have been
prescribed extensively, often in combination with each other. When toxic encephalopathy …

Child and adolescent bipolar disorder (BPD) is a serious psychiatric disorder that often
causes significant impairment in functioning. Pharmacological intervention is the …